Transplantation of mesenchymal stromal cell-derived mitochondria alleviates endothelial dysfunction in pre-clinical models of acute respiratory distress syndrome
Stem Cells Translational Medicine · 14.11.2025 · 14 (11)
DOI: 10.1093/stcltm/szaf053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 15.11.2025. Verfasst von Dayene de Assis Fernandes Caldeira und 8 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast BT9…. Hauptthemen laut MEDLINE: Respiratory Distress Syndrome, Mesenchymal Stem Cells, Mitochondria, Endothelial Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Medical Research Council Research, Brazilian Council for Scientific and Technological Development.
Abstract (Originalsprache)
Background
Pulmonary endothelial dysfunction with increased capillary permeability is a key aspect in the pathogenesis of acute respiratory distress syndrome (ARDS). It has been demonstrated that mesenchymal stromal cells (MSC) can modulate host cells through mitochondrial transfer. Although mitochondrial transplantation is a promising treatment strategy for conditions underpinned by mitochondrial dysfunction, its therapeutic potential in ARDS has not been sufficiently investigated. Herein, we tested the potential of MSC mitochondrial transplantation to restore functionality of the pulmonary endothelium in pre-clinical models of ARDS.
Methods
Mitochondria (mt) derived from human bone-marrow MSC were isolated and immediately used for transplantation to primary human pulmonary microvascular endothelial cells (HPMEC) in the presence of Escherichia coli lipopolysaccharide (LPS) or plasma samples from ARDS patients classified into hypo- and hyper-inflammatory phenotypes. Mitochondrial function, inflammatory status, and barrier integrity of HPMEC were assessed at 24 h. LPS- challenged mice were treated with MSC-mt intravenously, and the severity of lung injury and inflammatory response were evaluated.
Results
Exposure to LPS or ARDS plasma induced endothelial hyperpermeability associated with mitochondrial dysfunction. MSC-mt were readily internalized by HPMEC without cytotoxicity or inflammatory response, mitigating mitochondrial dysfunction and restoring barrier integrity. In vivo, administration of MSC-mt alleviated lung injury, reduced inflammatory cell infiltration in the alveoli and increased VE-cadherin mRNA levels in the lung tissue, indicating restoration of the alveolar-capillary barrier integrity.
Conclusion
This study demonstrated MSC mitochondrial transplantation as a promising therapeutic approach for treatment of endothelial dysfunction in the context of acute inflammation. Further exploration of mitochondrial transplantation in ARDS is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, United Kingdom.
- Laboratory of Pulmonary Investigation, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro CEP: 21941-902, Brazil.
- National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Rio de Janeiro, Brazil.
ORCID-Profile: Fernanda Ferreira Cruz, Anna Krasnodembskaya
Förderung
- UK Medical Research Council Research
- Brazilian Council for Scientific and Technological Development
Zitieren
APA
de Assis Fernandes Caldeira, D., Dutra Silva, J., Martins Melo, M., Gonzaga Veras, R., McAuley, D. F., Rieken Macedo Rocco, P., Silva, P. L., Cruz, F. F., & Krasnodembskaya, A. (2025). Transplantation of mesenchymal stromal cell-derived mitochondria alleviates endothelial dysfunction in pre-clinical models of acute respiratory distress syndrome. Stem Cells Translational Medicine, 14(11). https://doi.org/10.1093/stcltm/szaf053
Vancouver
de Assis Fernandes Caldeira D, Dutra Silva J, Martins Melo M, Gonzaga Veras R, McAuley DF, Rieken Macedo Rocco P, et al. Transplantation of mesenchymal stromal cell-derived mitochondria alleviates endothelial dysfunction in pre-clinical models of acute respiratory distress syndrome. Stem Cells Translational Medicine. 2025;14(11). doi:10.1093/stcltm/szaf053
BibTeX
@article{deAssisFernandesCaldeira2025,
author = {de Assis Fernandes Caldeira, Dayene and Dutra Silva, Johnatas and Martins Melo, Monique and Gonzaga Veras, Rodrigo and McAuley, Daniel F and Rieken Macedo Rocco, Patricia and Silva, Pedro Leme and Cruz, Fernanda Ferreira and Krasnodembskaya, Anna},
title = {Transplantation of mesenchymal stromal cell-derived mitochondria alleviates endothelial dysfunction in pre-clinical models of acute respiratory distress syndrome},
journal = {Stem Cells Translational Medicine},
year = {2025},
volume = {14},
number = {11},
doi = {10.1093/stcltm/szaf053}
}
EUVIMED